You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (67) |
Back to Search
Sitagliptin-associated drug reaction with eosinophilia and systemic symptoms (dress): a case report
- In: Posters: Hospital Pharmacy Section
- At: Bangkok (Thailand) (2014)
- Type: Poster
- Poster code: POS-HPS022
- By: YU, Jarlee (ChangGung Memorial Hospital, Taipei, Pharmacy, Taipei, China Taiwan)
- Co-author(s): Cheng, Chi-Yuan (ChangGung Memorial Hospital, Taipei, Taipei, China Taiwan)
Chung, Wen-Hung (ChangGung Memorial Hospital, Taipei, Taipei, China Taiwan)
Tsai, Tzu-Cheng (ChangGung Memorial Hospital, Taipei, Taipei, China Taiwan)
Chen, Wei-Li (ChangGung Memorial Hospital, Taipei, Taipei, China Taiwan)
Deng, Shin-Tarng (ChangGung Memorial Hospital, Taipei, Taipei, China Taiwan) - Abstract:
Sitagliptin, a dipeptidyl peptidase 4 (DPP-4) inhibitor, was approved for the treatment of type 2 diabetes mellitus (DM). Hypersensitivity reactions have been reported during post-marketing surveillance of sitagliptin. We report a rare case of sitagliptin-associated drug reaction with eosinophilia and systemic symptoms (DRESS). This was a case of..
The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026